SEARCH

Current Location: DOTmed News > Industry Headlines > This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

More Industry Headlines

Philips suspends CT and PET/CT production at Ohio facility Setback for customers and the company.

Varian's seven year patent dispute comes to an end Company will pay about $35 million.

FDA OKs GE's new CT scanner Ideal for challenging cases.

MRI technique can help treat concussion patients Measures white brain matter damage.

ABT's compact biomarker generator comes to Russia Ideal for the growing Russian market.

Special report: Contrast media One size does not fit all.

What's the big-picture impact of HIT on health care? Q&A with thought leader Bipin Thomas.

ClearMRI gets FDA clearance for MRI adaptor New option to extend the life of MRI systems.

Physician payment data now available CMS releases records and AMA pushes back.

Sebelius steps down from HHS post Sylvia Mathews Burwell to succeed Sebelius.

IBA spin-off, Novation ink PET radiopharmaceutical deal

by Brendon Nafziger , DOTmed News Associate Editor
Ion Beam Applications S.A.'s newly spun-off radiopharmaceutical wing IBA Molecular has inked a five-year deal with group purchasing organization Novation LLC to supply its member health care facilities with PET radiotracers.

Under the deal, announced Monday, IBA Molecular will supply imaging agents, including 18-Fluorodeoxyglucose, as well as provide educational and training services. The contract took effect July 1. Terms of the deal weren't disclosed.

Story Continues Below Advertisement

Siemens Healthcare Customer Services Tip for Biomed Departments:

Know What You're Worth. Your department is a more visible part of the financial picture. Click here to estimate the revenue value of your department to help you manage your budget>>>



IBA Molecular has 54 PET isotope facilities in Europe, North America and Asia. It also delivers agents for SPECT imaging worldwide.

SK Capital Partners holds a controlling stake in IBA Molecular, which was spun off from its Belgian parent company, which retains a minority stake, in April.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED